BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10982815)

  • 1. Isolation and characterization of constitutively active mutants of mammalian adenylyl cyclase.
    Hatley ME; Benton BK; Xu J; Manfredi JP; Gilman AG; Sunahara RK
    J Biol Chem; 2000 Dec; 275(49):38626-32. PubMed ID: 10982815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of forskolin and ATP with the cytosolic domains of mammalian adenylyl cyclase.
    Dessauer CW; Scully TT; Gilman AG
    J Biol Chem; 1997 Aug; 272(35):22272-7. PubMed ID: 9268376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic selection of regulatory mutants of mammalian adenylyl cyclases.
    Clapp P; Capper AB; Taussig R
    Methods Enzymol; 2002; 345():241-51. PubMed ID: 11665608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three discrete regions of mammalian adenylyl cyclase form a site for Gsalpha activation.
    Yan SZ; Huang ZH; Rao VD; Hurley JH; Tang WJ
    J Biol Chem; 1997 Jul; 272(30):18849-54. PubMed ID: 9228061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS.
    Tesmer JJ; Sunahara RK; Gilman AG; Sprang SR
    Science; 1997 Dec; 278(5345):1907-16. PubMed ID: 9417641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of forskolin interactions with type I, II, V, and VI adenylyl cyclases by Gs alpha.
    Sutkowski EM; Tang WJ; Broome CW; Robbins JD; Seamon KB
    Biochemistry; 1994 Nov; 33(43):12852-9. PubMed ID: 7947691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic selection of mammalian adenylyl cyclases insensitive to stimulation by Gsalpha.
    Zimmermann G; Zhou D; Taussig R
    J Biol Chem; 1998 Mar; 273(12):6968-75. PubMed ID: 9507003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase.
    Sunahara RK; Dessauer CW; Whisnant RE; Kleuss C; Gilman AG
    J Biol Chem; 1997 Aug; 272(35):22265-71. PubMed ID: 9268375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic selection in Saccharomyces of mutant mammalian adenylyl cyclases with elevated basal activities.
    Haney SA; Xu J; Lee SY; Ma CL; Duzic E; Broach JR; Manfredi JP
    Mol Genet Genomics; 2001 Aug; 265(6):1120-8. PubMed ID: 11523785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of forskolin-insensitive to forskolin-sensitive (mouse-type IX) adenylyl cyclase.
    Yan SZ; Huang ZH; Andrews RK; Tang WJ
    Mol Pharmacol; 1998 Feb; 53(2):182-7. PubMed ID: 9463474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A guanylyl cyclase from Paramecium with 22 transmembrane spans. Expression of the catalytic domains and formation of chimeras with the catalytic domains of mammalian adenylyl cyclases.
    Linder JU; Hoffmann T; Kurz U; Schultz JE
    J Biol Chem; 2000 Apr; 275(15):11235-40. PubMed ID: 10753932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the two cytosolic domains of mammalian adenylyl cyclase.
    Whisnant RE; Gilman AG; Dessauer CW
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6621-5. PubMed ID: 8692867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a soluble adenylyl cyclase activated by Gs alpha and forskolin.
    Tang WJ; Gilman AG
    Science; 1995 Jun; 268(5218):1769-72. PubMed ID: 7792604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The conserved asparagine and arginine are essential for catalysis of mammalian adenylyl cyclase.
    Yan SZ; Huang ZH; Shaw RS; Tang WJ
    J Biol Chem; 1997 May; 272(19):12342-9. PubMed ID: 9139678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical function of the Ras-associating domain as a primary Ras-binding site for regulation of Saccharomyces cerevisiae adenylyl cyclase.
    Kido M; Shima F; Satoh T; Asato T; Kariya K; Kataoka T
    J Biol Chem; 2002 Feb; 277(5):3117-23. PubMed ID: 11723130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic mechanism of the adenylyl and guanylyl cyclases: modeling and mutational analysis.
    Liu Y; Ruoho AE; Rao VD; Hurley JH
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13414-9. PubMed ID: 9391039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitation of signal onset and termination by adenylyl cyclase.
    Scholich K; Mullenix JB; Wittpoth C; Poppleton HM; Pierre SC; Lindorfer MA; Garrison JC; Patel TB
    Science; 1999 Feb; 283(5406):1328-31. PubMed ID: 10037603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volume overload cardiac hypertrophy exhibits decreased expression of g(s)alpha and not of g(i)alpha in heart.
    Di Fusco F; Hashim S; Anand-Srivastava MB
    Am J Physiol Cell Physiol; 2000 Oct; 279(4):C990-8. PubMed ID: 11003579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation in the switch 3 region of Gsalpha in a patient with Albright hereditary osteodystrophy impairs GDP binding and receptor activation.
    Warner DR; Weng G; Yu S; Matalon R; Weinstein LS
    J Biol Chem; 1998 Sep; 273(37):23976-83. PubMed ID: 9727013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenylyl cyclase type II domains involved in Gbetagamma stimulation.
    Weitmann S; Schultz G; Kleuss C
    Biochemistry; 2001 Sep; 40(36):10853-8. PubMed ID: 11535062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.